Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.45
Delayed Data
As of Aug 27
 +0.07 / +5.07%
Today’s Change
1.31
Today|||52-Week Range
3.00
-44.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$80.3M

Company Description

BIOLASE, Inc. is a medical technology company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, in-office, chair-side milling machines and three-dimensional printers. The company offers two categories of laser system products: Waterlase systems and Diode systems. Its flagship product category, the Waterlase system, uses a patented combination of water and laser to perform most procedures, performs using dental drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. It also offers a family of Diode laser system products, including its ezlase soft tissue diode laser, to perform soft tissue and cosmetic procedures, including tooth whitening. The company also manufactures and sells accessories and disposables for its laser systems, such as hand pieces, laser tips and tooth whitening gel. BIOLASE was founded in 1987 and is headquartered in Irvine, CA.

Contact Information

BIOLASE, Inc.
4 Cromwell
Irvine California 92618
P:(949) 361-1200
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Harold C. FlynnPresident, Chief Executive Officer & Director
Richard R. WhippVice President-Operations
David C. DreyerChief Financial Officer & Senior Vice President
Dmitri BoutoussovVice President-Research & Development
Orlando P. RodriguesChief Marketing Officer & Vice President